Company Search:
Advanced Search
Sponsored Links
Abbott Laboratories Company Snapshot
Abbott Laboratories operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abbott Laboratories with three other companies in this sector in the United States: AstraZeneca PLC (2017 sales of $22.47 billion of which 100% was Pharmaceuticals), Abbvie Inc ($28.22 billion of which 100% was Pharmaceutical Products), and Eli Lilly and Company ($22.87 billion of which 44% was Human pharmaceutical products - Endocrin).

Sales Analysis. During the year ended December of 2017, sales at Abbott Laboratories were $27.39 billion. This is an increase of 31.3% versus 2016, when the company's sales were $20.85 billion. This was the third consecutive year of growth at Abbott Laboratories. Sales of Vascular Products saw an increase that was more than double the company's growth rate: sales were up 207.7% in 2017, from $2.90 billion to $8.91 billion. Not all segments of Abbott Laboratories experienced an increase in sales in 2017: sales of Other fell 30.8% to $1.65 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Abbott Laboratories
  Stock Performance Chart for Abbott Laboratories
  Stock Data: Recent Stock Performance:
  Current Price (1/11/2019): 69.33
(Figures in U.S. Dollars)
1 Week 1.8%   13 Weeks -2.0%  
4 Weeks 0.0%   52 Weeks 17.8%  
Abbott Laboratories Key Data:
  Ticker: ABT Country: United States
  Exchanges: NYSE FRA LON MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 27,390,000,000
(Year Ending Jan 2018).
Employees: 99,000
  Currency: U.S. Dollars Market Cap: 121,766,569,109
  Fiscal Yr Ends: December Shares Outstanding: 1,756,333,032
  Share Type: Common Closely Held Shares: 12,603,779
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.